Thomas M. Devlin

1.7k total citations
73 papers, 1.3k citations indexed

About

Thomas M. Devlin is a scholar working on Molecular Biology, Clinical Biochemistry and Plant Science. According to data from OpenAlex, Thomas M. Devlin has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 16 papers in Clinical Biochemistry and 9 papers in Plant Science. Recurrent topics in Thomas M. Devlin's work include Metabolism and Genetic Disorders (16 papers), Mitochondrial Function and Pathology (15 papers) and Mycotoxins in Agriculture and Food (9 papers). Thomas M. Devlin is often cited by papers focused on Metabolism and Genetic Disorders (16 papers), Mitochondrial Function and Pathology (15 papers) and Mycotoxins in Agriculture and Food (9 papers). Thomas M. Devlin collaborates with scholars based in United States, Mexico and Poland. Thomas M. Devlin's co-authors include G. Boxer, John J. Ch'ih, Albert L. Lehninger, Cecil Cooper, S. Tsuyoshi Ohnishi, Salvador Uribe‐Carvajal, James L. Gamble, Charles L. Wadkins, Robert J. McKenzie and Alfredo Saavedra‐Molina and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Thomas M. Devlin

72 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas M. Devlin United States 18 747 242 173 157 151 73 1.3k
Frank L. Siegel United States 25 1.0k 1.4× 188 0.8× 148 0.9× 167 1.1× 218 1.4× 73 1.7k
F C Kauffman United States 20 410 0.5× 159 0.7× 116 0.7× 82 0.5× 168 1.1× 57 1.4k
Erwin J. Landon United States 23 1.1k 1.5× 263 1.1× 113 0.7× 236 1.5× 194 1.3× 55 2.0k
Lee W. Grotyohann United States 11 1.2k 1.5× 319 1.3× 280 1.6× 122 0.8× 192 1.3× 13 2.1k
Lawrence M. Pinkus United States 18 552 0.7× 164 0.7× 119 0.7× 70 0.4× 134 0.9× 24 1.1k
F. Guerrieri Italy 26 1.3k 1.7× 220 0.9× 181 1.0× 172 1.1× 245 1.6× 69 1.8k
Sosamma J. Berger United States 20 1.1k 1.4× 130 0.5× 60 0.3× 98 0.6× 209 1.4× 34 1.7k
D. Hegner Germany 25 909 1.2× 406 1.7× 166 1.0× 167 1.1× 90 0.6× 80 2.0k
Michele Lorusso Italy 25 1.2k 1.6× 294 1.2× 156 0.9× 173 1.1× 290 1.9× 52 1.8k
G. D. V. van Rossum United States 21 595 0.8× 262 1.1× 91 0.5× 111 0.7× 134 0.9× 66 1.2k

Countries citing papers authored by Thomas M. Devlin

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Devlin more than expected).

Fields of papers citing papers by Thomas M. Devlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Devlin. The network helps show where Thomas M. Devlin may publish in the future.

Co-authorship network of co-authors of Thomas M. Devlin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Devlin. A scholar is included among the top collaborators of Thomas M. Devlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Devlin. Thomas M. Devlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devlin, Thomas M.. (2004). How I Became a Biochemist. IUBMB Life. 56(1). 51–52.
2.
3.
Soslau, Gerald, Robert J. McKenzie, Isadore Brodsky, & Thomas M. Devlin. (1995). Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1268(1). 73–80. 23 indexed citations
4.
Uribe‐Carvajal, Salvador & Thomas M. Devlin. (1994). Tri-Calciphor (16,16-dimethyl-15-dehydroprostagalndin B1 trimer)-mediated mitochondrial Ca2+ movements: modulation by phosphate. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1225(2). 144–148. 1 indexed citations
5.
Villalobos‐Molina, Rafael & Thomas M. Devlin. (1994). Effects of Tri-Calciphor (Trimer of 16,16-Dimethyl-15-dehydroprostaglandin B1) on Glucose Metabolism in Liver Cells. Biochemical and Biophysical Research Communications. 201(3). 1457–1463. 1 indexed citations
6.
Park, Yongjung, Thomas M. Devlin, & Dean P. Jones. (1994). Protection of Hepatocytes Against Death Due to Mitochondrial Failure: Effect of Di-Calciphor on Antimycin A-Induced Toxicity. Toxicology and Applied Pharmacology. 126(1). 33–38. 4 indexed citations
7.
Lin, Rick C.S., Diane F. Matesic, Robert J. McKenzie, Thomas M. Devlin, & Dag K.J.E. Von Lubitz. (1993). Neuroprotective activity of dimer of 16,16′-dimethyl-15-dehydroprostaglandin B1 (di-Calciphor) in cerebral ischemia. Brain Research. 606(1). 130–134. 6 indexed citations
8.
Lubitz, Dag K.J.E. Von, Robert J. McKenzie, R.C.-S. Lin, Thomas M. Devlin, & P. Skolnick. (1993). MK-801 is neuroprotective but does not improve survival in severe forebrain ischemia. European Journal of Pharmacology. 233(1). 95–100. 15 indexed citations
9.
Ch'ih, John J., et al.. (1993). Nuclear Translocation of Aflatoxin B1-Protein Complex. Biochemical and Biophysical Research Communications. 190(1). 186–191. 8 indexed citations
10.
Lubitz, Dag K.J.E. Von, R.C.-S. Lin, Robert J. McKenzie, Thomas M. Devlin, & R. Tyler McCabe. (1992). A novel treatment of global cerebral ischaemia with a glycine partial agonist. European Journal of Pharmacology. 219(1). 153–158. 59 indexed citations
11.
Lubitz, Dag K.J.E. Von, Robert J. McKenzie, Alexander Kalenak, Rick C.S. Lin, & Thomas M. Devlin. (1992). Treatment of severe brain ischemia with di- and tri-Calciphor (dimer and trimer of 16,16′-dimethyl prostaglandin B1). European Journal of Pharmacology. 216(1). 37–45. 5 indexed citations
12.
Devlin, Thomas M., et al.. (1991). The in vivo disposition of aflatoxin B1 in rat liver. Biochemical and Biophysical Research Communications. 179(2). 1095–1100. 10 indexed citations
13.
Ch'ih, John J., et al.. (1991). Isolated hepatocytes are capable of excreting aflatoxin metabolites. Biochemical and Biophysical Research Communications. 178(3). 1002–1007. 4 indexed citations
14.
Saavedra‐Molina, Alfredo, Salvador Uribe‐Carvajal, & Thomas M. Devlin. (1990). Control of mitochondrial matrix calcium: Studies using fluo-3 as a fluorescent calcium indicator. Biochemical and Biophysical Research Communications. 167(1). 148–153. 30 indexed citations
15.
Ch'ih, John J., et al.. (1989). 2(3)-Tert-Butyl-4-Hydroxyanisole Inhibits Oxidative Metabolism of Aflatoxin B1 in Isolated Rat Hepatocytes. Experimental Biology and Medicine. 192(1). 35–42. 5 indexed citations
16.
Devlin, Thomas M., et al.. (1988). Modification of protein synthetic components by aflatoxin B1. Biochemical Pharmacology. 37(8). 1481–1486. 4 indexed citations
17.
Esfahani, Maryam Nasr, et al.. (1980). Effect of sterols on diphenylhexatriene fluorescence in lecithin vesicles. FEBS Letters. 114(1). 48–50. 8 indexed citations
18.
Devlin, Thomas M., et al.. (1977). Efficiency of do-it-yourself slide-tape programs as an alternative to the lecture in medical biochemistry. Academic Medicine. 52(2). 157–9. 4 indexed citations
19.
Devlin, Thomas M.. (1974). The teaching of biochemistry to non scientists. Biochemical Education. 2(4). 61–62. 1 indexed citations
20.
Ciaccio, Edward I., et al.. (1967). Screening data from selected in vitro enzymatic systems. II. Compounds specifically selected for the dehydrogenase inhibition screens.. PubMed. 27(10 Pt 2). 1070–104. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank L. Siegel Breakdown of academic impact, for papers by F C Kauffman Breakdown of academic impact, for papers by Erwin J. Landon Breakdown of academic impact, for papers by Lee W. Grotyohann Breakdown of academic impact, for papers by Lawrence M. Pinkus Breakdown of academic impact, for papers by F. Guerrieri Breakdown of academic impact, for papers by Sosamma J. Berger Breakdown of academic impact, for papers by D. Hegner Breakdown of academic impact, for papers by Michele Lorusso Breakdown of academic impact, for papers by G. D. V. van Rossum
Rankless by CCL
2026